Anatara Lifesciences Ltd (AU:ANR) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Anatara Lifesciences Ltd successfully raised $274,500 through a Share Purchase Plan (SPP), complementing a recent $750,000 placement with institutional investors. The funds will support the company’s Phase II clinical study for its GaRP medication targeting irritable bowel syndrome and an anti-obesity project. This financial boost marks a significant step forward for Anatara’s innovative gastrointestinal and weight management solutions.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.